WeVote
Log In

Bill

Bill

SB 2274

RELATING TO MEDICAL CANNABIS.

2026 Regular Session Introduced by Mike Gabbard and 4 co-sponsors

SB 2274 modifies Hawaii's medical cannabis regulations, advancing through committee review to determine updated patient eligibility, regulatory standards, or licensing requirements.

Referred to PSM/HHS, JDC.
#dle #inspection #medicalcannabis #medicalrecords #repeal
0
WeVote Research Nonpartisan
Bill Summary · SB 2274

Legislative bill overview

SB 2274 relates to medical cannabis in Hawaii, though the specific provisions are not detailed in the available information. The bill was introduced in January 2026 and has completed its first reading, currently awaiting committee review by the Public Safety and Human Services (PSM/HHS) and Judiciary (JDC) committees.

Why is this important

Medical cannabis policy directly affects patients seeking alternative treatment options, healthcare providers' prescribing practices, and state regulatory frameworks. Hawaii's approach to medical cannabis influences patient access, business development in the cannabis industry, and alignment with federal-state legal tensions.

Potential points of contention

  • Scope of patient eligibility: Disagreement over which medical conditions qualify patients for medical cannabis access and whether the list should expand or remain restrictive
  • Regulatory oversight: Debate over which state agencies should regulate medical cannabis production, distribution, and quality control, and how stringently
  • Federal-state legal conflict: Tension between state legalization and federal prohibition, affecting banking, interstate commerce, and law enforcement coordination

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.